CompletedPhase 4ketamine

Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions

Sponsored by Drexel University College of Medicine

NCT ID
NCT00596050
Target Enrollment
50 participants
Start Date
2006-08
Est. Completion
2008-06

About This Study

There are multiple retrospective studies detailing the use of etomidate in pediatric procedural sedation but few to no prospective clinical trials. None have compared etomidate to ketamine, currently the most commonly used sedative in the emergency department for pediatric procedural sedation. The investigators propose a randomized, controlled trial comparing etomidate versus ketamine for procedural sedation for fracture reduction for children presenting with extremity fracture requiring sedation for reduction. The investigators hypothesize that etomidate in combination with fentanyl will have similar reduction of distress and procedural recall as ketamine in combination with midazolam.

Conditions Studied

Conscious Sedation Failure During Procedure

Interventions

  • ketamine and midazolam
  • etomidate, fentanyl, and lidocaine

Eligibility

Age:5 Years - 18 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* age 5-18 years
* extremity fracture requiring reduction with sedation in emergency department

Exclusion Criteria:

* allergy to etomidate, midazolam, fentanyl, ketamine, lidocaine
* multi-system trauma
* history of psychosis
* pregnancy
* illicit drug use
* developmental delay
* non-english speaker

Study Locations (1)

St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source